Brief: Beam Therapeutics Buys Early-Stage Life Sciences Company
03/07/2025 21:42
July 3 (Reuters) - Beam Therapeutics Inc BEAM.O: BEAM THERAPEUTICS INC - BUYS EARLY-STAGE LIFE SCIENCES COMPANY - SEC FILING BEAM THERAPEUTICS INC - POTENTIAL ADDITIONAL PAYMENTS UP TO $89 MILLION - SEC FILING BEAM THERAPEUTICS INC - MAXIMUM OF 5.2 MILLION MILESTONE SHARES ISSUABLE AT $17.01 PER SHARE - SEC FILING Further company coverage: BEAM.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beam Therapeutics
See all newsBeam Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Beam Therapeutics Q1 net loss narrows beating analyst estimates
U.S. STOCKS ON THE MOVE-ADMA Biologics, Nanobiotix, DraftKings
U.S. STOCKS ON THE MOVE-BWX, Generac, Cintas
U.S. STOCKS ON THE MOVE-Arm, On Holding, Sarepta